S. Dell'Aniello

First name
S.
Last name
Dell'Aniello
Brassard, P., Wu, J. W., Ernst, P., Dell'Aniello, S., Smiechowski, B., & Suissa, S. (2017). The effect of statins on influenza-like illness morbidity and mortality. Pharmacoepidemiol Drug Saf. http://doi.org/10.1002/pds.4112
View
Suissa, S., Dell'Aniello, S., & Ernst, P. (2017). Concurrent use of long-acting bronchodilators in COPD and the risk of adverse cardiovascular events. Eur Respir J. http://doi.org/10.1183/13993003.02245-2016
View
Renoux, C., Dell'Aniello, S., Brenner, B., & Suissa, S. (2017). Bias from depletion of susceptibles: the example of hormone replacement therapy and the risk of venous thromboembolism. Pharmacoepidemiol Drug Saf. http://doi.org/10.1002/pds.4197
View
Renoux, C., Vahey, S., Dell'Aniello, S., & Boivin, J. F. (2017). Association of Selective Serotonin Reuptake Inhibitors With the Risk for Spontaneous Intracranial Hemorrhage. JAMA Neurol. http://doi.org/10.1001/jamaneurol.2016.4529
View
Douros, A., Dell'Aniello, S., H. Y. Yu, O., Filion, K. B., Azoulay, L., & Suissa, S. (2018). Sulfonylureas as second line drugs in type 2 diabetes and the risk of cardiovascular and hypoglycaemic events: population based cohort study. Bmj. http://doi.org/10.1136/bmj.k2693
View
. Y. Loo, S., Coulombe, J., Dell'Aniello, S., Brophy, J. M., Suissa, S., & Renoux, C. (2018). Comparative effectiveness of novel oral anticoagulants in UK patients with non-valvular atrial fibrillation and chronic kidney disease: a matched cohort study. BMJ Open. http://doi.org/10.1136/bmjopen-2017-019638
View
Suissa, S., Dell'Aniello, S., & Ernst, P. (2018). Comparative effectiveness of LABA-ICS versus LAMA as initial treatment in COPD targeted by blood eosinophils: a population-based cohort study. Lancet Respir Med. http://doi.org/10.1016/s2213-2600(18)30368-0
View
Sinyavskaya, L., Gauthier, S., Renoux, C., Dell'Aniello, S., Suissa, S., & Brassard, P. (2018). Comparative effect of statins on the risk of incident Alzheimer disease. Neurology. http://doi.org/10.1212/wnl.0000000000004818
View
Secrest, M. H., Platt, R. W., Dormuth, C. R., Chateau, D., Targownik, L., Nie, R., et al. (2019). Extreme restriction design as a method for reducing confounding by indication in pharmacoepidemiologic research. Pharmacoepidemiol Drug Saf. http://doi.org/10.1002/pds.4708
View
Douros, A., Dell'Aniello, S., Dehghan, G., Boivin, J. F., & Renoux, C. (2019). Degree of serotonin reuptake inhibition of antidepressants and ischemic risk: A cohort study. Neurology. http://doi.org/10.1212/wnl.0000000000008060
View